Cala Health
Overview
Cala Health develops bioelectronic medicines that use targeted neuromodulation to treat chronic diseases by modulating neural circuits. The company's proprietary technology platform enables precise, non-invasive nerve stimulation to address conditions across multiple therapeutic areas.
More in Neurotechnology
Latest industry news
Aurenar Raises $5.7M to Push Stroke Neuromodulation Device Toward Market
2026-07-29 · Funding
Neuvotion Brings Brain-Computer and Brain-Body Interface Technologies to Market as Nature Medicine Study Lands
2026-07-28 · Product
FDA Grants De Novo Approval to Modius Spero Neuromodulation Device for PTSD
2026-07-27 · Policy
BRYM Raises €650K to Build Wearable Neurofeedback Platform for Consumer and Clinical Markets
2026-07-26 · Funding
Company details
Category
🏢 Neurotechnology
Funding
Private
Listed
2026-07-10
Is this your company?
Claim this listing to add your logo, full description, team, and products. Premium listings get featured placement.
Claim & upgrade listingAdvertise
Reach neurotech professionals
Newsletter sponsorships, featured listings, and sponsored articles.
View packages →